sorafenib Tablets, film coated 200 mg

Dossier type
Dossier status
Ready to file
Country of origin
GMP approvals
Manufacturer #15733
One of the leading manufacturers in cosmetic and medicinal products in the South American Continent. The company has been committed since 1990-is to developing and manufacturing high-quality products that allow healing and improve someone’s life. They are a major exporter of its therapies to different regions such as Latin America and Asia. Medicine is manufactured for pain, gastroenterology, hepatology, and cardiology.

Manufacturer usually replies in 17 days


Sorafenib is a kinase inhibitor used in the treatment of primary kidney cancer called advanced renal cell carcinoma, advanced primary liver cancer called hepatocellular carcinoma, FLT3- ITD positive AML and radioactive iodine resistant advanced thyroid cancer. The survival rates amongst patients who are administered were 60% in the 1st year, 35% in the 2nd year, and 26% in the third year. A wide-ranging study conducted in Asia pacific also proved the efficacy of this treatment.
Sorafenib is primarily marketed as Nexavar. But given its use around the world, it is manufactured and sold by suppliers and labellers around the world. Bayer and Onyx Pharmaceuticals developed and marketed Sorafenib. Sorafenib was approved by the U.S. Food and Drug Administration in 2005 and received European Commission’s marketing authorization in 2006.

Forms and Dosage

Sorafenib is sold as a tablet of 200 mg strength. The dosage in the treatment of Renal Cell Carcinoma as Indicated is 400 mg every 12 hours or twice a day. In the treatment of Hepatocellular Carcinoma, the recommended dosage is 400 mg administered every 12 hours and in the treatment of thyroid cancer the recommended initial dosage is 400 mg, however, in the cases of toxicity, the doctor will monitor and change the dosage as needed. The median treatment during using this medication is a little over 5 months.

The wholesale cost of Sorafenib

Sorafenib is an expensive medication. In the USA, the consumers have to pay for, Nexvar oral tablet 200 mg, around $20,870 for a supply of 120 tablets. In Europe, a year’s treatment costs $57,232 in the UK but much lower, at $49,715 in Spain, and lower still, $44,543 in France. Given the high cost and it life-saving nature, many countries in the develop world subsidize or refund the cost of this treatment.
In India, Bayer sold a month's supply, 120 tablets for US$3,900. However, the Indian Patent Office granted Natco Pharma a license to manufacture generic Sorafenib 2012, this resulting in the price coming down by 97%.

How does Sorafenib work?

Sorafenib is a kinase inhibitor .Sorafenib blocks tumor cell growth in many ways. Its actions in the body stop the signals that tell cancer cells to grow while also preventing cancer cells from forming new blood vessels, thus stopping their growth. Sorafenib does only target enzymes on the surface of cancer cells but also within the cell. Many of these targets are involved in the making of blood vessels. After getting the desired information using targeted therapy, it is used to create a targeted therapy to attack the cancer cells without damaging the normal cells.

Finding Sorafenib Manufacturers and Suppliers

The process of finding trusted Sorafenib manufacturers and Sorafenib suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities.
The robust search engine makes it convenient to search for manufacturers and suppliers of Sorafenib. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.